Dr. McClintock said the study is convincing in part because it used data from TRICARE, which sets a lower testosterone level even than AUA guidelines for determining if a patient is eligible for testosterone therapy.
“It would suggest that those are the real low testosterone patients, not necessarily men who heard an ad or went to a test center,” noted, associate professor of urology at Scott & White Medical Center, Temple, Texas, who attended the presentation but was not involved in the study. “It’s preliminary, but it’s very interesting. It hasn’t been shown before.”
The Department of Defense funded the study. Dr. McClintock reported having no relevant financial disclosures.
SOURCE: McClintock T. AUA Annual Meeting. Abstract MP13-19.